Published in Tunis Med on May 01, 2003
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood (2005) 6.07
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med (2006) 2.18
Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol (2002) 1.74
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood (2011) 1.23
Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) (2013) 1.22
Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta (2003) 1.17
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood (2011) 1.09
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther (2007) 1.06
AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res (2013) 0.98
Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr (2006) 0.96
High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol (2012) 0.96
Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis (2013) 0.95
Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review. Tunis Med (2007) 0.88
Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci (2011) 0.87
Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol (2013) 0.86
Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2009) 0.85
Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int (2014) 0.85
Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine (2008) 0.84
Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis (2007) 0.83
Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease. Digestion (2011) 0.83
Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J Gastroenterol (2009) 0.82
Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol (2013) 0.81
Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease. J Neuroimmunol (2006) 0.81
Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol (2007) 0.81
Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary Pancreat Dis Int (2011) 0.80
T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm (2002) 0.80
[IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients]. Tunis Med (2010) 0.79
Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol (2003) 0.79
Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant (2011) 0.79
Acute rejection episodes after kidney transplantation. Saudi J Kidney Dis Transpl (2009) 0.79
Role of genetic polymorphisms in factor H and MBL genes in Tunisian patients with immunoglobulin A nephropathy. Int J Nephrol Renovasc Dis (2010) 0.78
Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in Tunisia. C R Biol (2013) 0.78
Autoimmune polyglandular syndrome type II after bone marrow transplant: real transfer or acceleration of a programmed disease? Exp Clin Transplant (2012) 0.78
[Hepatitis C in kidney transplantation: comparative study between two Maghrebin centers: Casablanca and Tunis]. Tunis Med (2010) 0.78
VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. J Neuroimmunol (2009) 0.78
Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome). Clin Mol Allergy (2012) 0.77
CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection. Iran J Kidney Dis (2011) 0.77
Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol (2009) 0.77
[Deficient expression of leukocyte adhesion proteins. A new Tunisian case]. Tunis Med (2006) 0.77
Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons. Dig Dis (2015) 0.76
Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J Gastroenterol (2010) 0.76
Anti-thrombomodulin antibodies and venous thrombosis. Blood Coagul Fibrinolysis (2004) 0.76
Anti-CCP antibodies, rheumatoid factors and anti-keratin antibodies: clinical value in established rheumatoid arthritis. Tunis Med (2011) 0.76
Contribution to the description of the beta-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin (2004) 0.76
Omenn syndrome: two case reports. Acta Dermatovenerol Croat (2013) 0.76
Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families. Int J Nephrol Renovasc Dis (2010) 0.76
Correction: Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One (2015) 0.75
[Bronchopulmonary aspergillosis: study of 17 cases]. Tunis Med (2002) 0.75
Primary immunodeficiencies : Report of 33 Pediatric Tunisian cases. Tunis Med (2016) 0.75
[Immunological study in sickle cell disease patients: importance of the complement system]. Tunis Med (2003) 0.75
Budd-Chiari syndrome in a boy with β thalassemia major (a study of a new case). J Pediatr Hematol Oncol (2013) 0.75
Hypocalcaemia due to hypoparathyroidism in β-thalassemia major. A study of a new case. Tunis Med (2011) 0.75
Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report. Pediatr Transplant (2007) 0.75
[Pulmonary aspergillosis in a child with chronic granulomatous disease]. Tunis Med (2003) 0.75
[The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases]. Tunis Med (2003) 0.75
A rare cause of fever associated with leukopenia in a renal transplant patient. Nephrol Dial Transplant (2004) 0.75
[Diabetes following kidney transplantation. Report of 35 cases]. Tunis Med (2004) 0.75
Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. Hemodial Int (2008) 0.75
[Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases]. Tunis Med (2013) 0.75
Successful treatment of mycophenolate mofetil in a child with refractory Evans syndrome. J Pediatr Hematol Oncol (2010) 0.75
Cytogenetic assessment of Fanconi anemia in children with aplastic anemia in Tunisia. J Pediatr Hematol Oncol (2013) 0.75
Salmonella enteriditis inducing cutaneous leucocytoclasic vasculitis: An unusual complication in a patient with an interleukine- 12 receptor beta-1 deficiency. Tunis Med (2015) 0.75
[Vascular trombosis of renal graft: 9 cases]. Tunis Med (2008) 0.75